Start with the obvious line: purchase price per unit. A disposable consumable is bought, used once, and discarded. A reusable device is bought once and used many times. On purchase price alone, the reusable device looks cheaper after enough uses, and the disposable looks cheaper for low volumes. That comparison is incomplete, and it misleads buyers who stop there.
Add the reprocessing line. Reusable devices must be cleaned, disinfected or sterilized, inspected, and repackaged between uses. Each step costs staff time, consumables, equipment use, and quality checks. Reprocessing also has a failure rate: devices that fail inspection are repaired or discarded, and the cost of those failures belongs in the reusable column. A facility without a reprocessing unit cannot run reusable devices at all, and the cost of building one belongs in the comparison too.
Add the logistics line. Disposable consumables are stocked by therapy and volume, with par levels and regular deliveries. The logistics cost is storage space and ordering effort. Reusable devices are stocked as equipment: they are tracked individually, scheduled for maintenance, and pulled from service for repair. The tracking and maintenance effort is a real cost, and it grows with the number of reusable devices in circulation.
Add the availability line. A disposable consumable that is out of stock means a therapy cannot be delivered until the next delivery. A reusable device that is in reprocessing or repair is equally unavailable. Both stockouts cost the facility in delayed procedures and in workaround effort. The availability question is which stockout is easier to prevent: holding more disposable stock, or holding more reusable units and more reprocessing capacity. The answer depends on the therapy volume and the lead times involved.
Add the risk line, carefully. Reusable devices carry cross-contamination risk if reprocessing fails, and the cost of a reprocessing failure includes patient harm, investigation, and reputational damage. Disposable devices avoid reprocessing risk entirely, because each unit is used once. This article does not put a number on either risk, because no such number is documented for the lines on this site. The point is that the risk line belongs in the comparison even without a number, and a comparison that omits it is biased toward reusables.
Add the waste line, honestly. Disposable devices generate waste on every use: packaging, the device itself, and disposal handling. Reusable devices generate less per-use waste but generate reprocessing waste: water, energy, chemicals, and packaging for sterile barrier systems. Waste costs include disposal fees and, where applicable, environmental reporting. A comparison that counts disposable waste but ignores reprocessing waste is as biased as one that ignores reprocessing cost.
The math, in outline, is: disposable cost per treatment equals the unit price plus the waste and disposal cost plus the stocking cost. Reusable cost per treatment equals the purchase price divided by the number of uses, plus the reprocessing cost per use, plus the maintenance and tracking cost per use, plus the failure and replacement cost per use, plus the waste cost per use. The cheaper option is the one with the lower total per treatment for the facility's actual volumes, not the one with the lower purchase price.
Volume decides most comparisons. High-volume, standardized therapies favor disposables when reprocessing capacity is limited, because the per-treatment math is simple and the availability risk is controlled by stock. Low-volume, specialized therapies favor reusables when the device is expensive and the reprocessing unit already exists, because the purchase price spreads across enough uses. Mid-volume therapies need the full calculation, and the answer varies by facility.
For the lines on this site, the comparison is mostly settled by the product type. Suction catheters, infusion pump reservoirs, catheter kits, and pressure transducers in this catalog are single-use consumables; the documented closed suction catheter is explicitly single use and must not be re-sterilized. The buying question for these lines is not disposable versus reusable, but which disposable configuration, in what quantities, at what confirmed price. The quote confirmation page lists what every quote confirms.
Run the full calculation for any line where both options genuinely exist, and run it with the facility's own volumes, reprocessing costs, and lead times. A calculation built on another facility's numbers is not a calculation. The homepage lists the product lines on this site, and each line's page states what is documented and what must be confirmed.
Regulatory and documentation burden for reusables is a cost line that buyers often miss. A reusable device needs a validated reprocessing procedure, documented for each device type, with records for every reprocessing cycle. The validation must cover cleaning, disinfection or sterilization, inspection, and packaging, and it must be repeated when the device, the detergent, or the equipment changes. The documentation burden is ongoing, not one-time, and it falls on the facility's sterile services team. A facility that cannot staff that burden cannot run reusables safely, whatever the purchase price comparison says.
Surge and outbreak resilience favors disposables in a specific way: disposable stock can be scaled by ordering more, while reusable capacity can only be scaled by adding reprocessing shifts, equipment, or staff. During a surge, the reprocessing unit becomes the bottleneck for every reusable device in the facility at once. Disposable programs scale linearly with deliveries, and the constraint is the supplier's lead time rather than the facility's internal capacity. Facilities that plan for surges keep a disposable buffer for their highest-volume lines, even if their routine choice is reusable.
Environmental reporting is the last line in the comparison, and it is growing. Facilities report clinical waste volumes, and some report carbon footprints that include reprocessing energy and water. Disposable programs report higher per-treatment waste volumes; reusable programs report reprocessing energy, water, and chemical use. Neither side of the comparison is free of environmental cost, and the reporting rules differ by jurisdiction. Buyers should check which metrics their facility reports before assuming one option is environmentally superior.
Hidden costs in the comparison include stockouts and rush orders. A stockout of a disposable consumable delays procedures and forces rush deliveries at premium freight rates. A stockout of a reusable device's reprocessing capacity has the same effect through a different route: procedures wait for devices to come back from reprocessing. Both costs belong in the comparison, and both are usually omitted from it, because they appear in different budgets from the purchase price. A facility that tracks stockout frequency and rush freight cost per line can put numbers on these lines; a facility that does not track them is guessing.
Contracting shapes the comparison through volume tiers and price locks. Disposable contracts often include volume tiers: higher volumes earn lower unit prices, which rewards accurate forecasting and penalizes fragmented ordering across suppliers. Reusable contracts include service terms: maintenance coverage, loan units, and parts availability over the equipment's life. A buyer comparing the two should compare the contracted total, not the list price, and should check the contract length against the planning horizon: a one-year disposable contract and a five-year equipment contract are not directly comparable without annualizing both.
Financing structure changes the comparison in ways that purchase price hides. Capital budgets buy equipment, operating budgets buy consumables, and the two budgets are signed off by different people on different cycles. A reusable purchase that needs capital approval may wait a year for the capital cycle, while a disposable purchase from the operating budget can start next month. Conversely, a disposable program that grows consumes operating budget every month, while a reusable fleet bought once costs little month to month. Buyers should map each option to the budget that funds it before comparing prices, because an option that cannot be funded on time is not an option.